Augmentation of endotoxin-induced fibrin deposits by pregnancy and estrogen-progesterone treatment.
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects*; D003864:Depression, Chemical; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000494:pharmacology*; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004731:Endotoxins / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005337:Fibrin / Q000378:metabolism*; D006400:Hematocrit; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007678:Kidney Glomerulus / Q000187:drug effects; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects*; D011374:Progesterone / Q000008:administration & dosage / Q000494:pharmacology*; D011555:Pseudopregnancy; D051381:Rats; D012790:Shwartzman Phenomenon / Q000139:chemically induced
D004731:Endotoxins; D011374:Progesterone; D004054:Diethylstilbestrol; D005337:Fibrin